~~<i id='22E5A0BD5E'><strike id='22E5A0BD5E'><tt id='22E5A0BD5E'><pre id='22E5A0BD5E'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

entertainment

author：leisure time 2025-08-04 03:42:05 - browse：5491

People waiting in line, standing in between red rope. -- first opinion coverage from STAT — Adobe

Health care providers and health insurance companies are closing the books on their third quarters, and one major question continues to hang over them: How much care is everyone actually getting, now that Covid-19 isn’t scaring so many away from doctors and hospitals?

The short answer, according to financial analysts and the companies themselves: It appears people continue to fill prescriptions, see their doctors, and get recommended surgeries.

For health insurers, those trends mean they will have to deposit more money into the bank accounts of providers — perhaps more than they predicted.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Chemotherapy shortages won’t get better under Biden’s latest plan

knowledge

leisure time

Wikipedia

hotspot

entertainment

File-SudaneserefugeeswhofledtheconflictinSudangatherMonday,July10,2023,attheZaboutrefugeeCampinGozBe

WSS

5 wounded, 2 critically, in Michigan shopping center shooting

Putin woos African leaders at a summit in Russia with promises of expanding trade and other ties

HCA says smaller share of spending going to labor

SCOTUS to consider access to abortion pill mifepristone

Why sickle cell disease is getting the first CRISPR treatment

Young Chinese opt out of the rat race and pressures at home to pursue global nomad lifestyle

hotspot

entertainment

knowledge

Bright Health sells Medicare Advantage business to Molina

What causes an itch? Researchers may have solved the mystery

Jerome Adams on the need for new antivirals for Covid

The woman behind the Dana Farber

Medicare details structure of new drug price negotiation program

Americans' trust in science, scientist continues decline: Report

Dobbs anniversary: the lost opportunity of abortion as health care

Supreme Court wrestles with OxyContin maker's bankruptcy deal

Tori Bowie and the unacceptable rates of Black maternal death

FDA needs staff influx to meet gene therapy needs, Marks says

leisure time

Trump PAC spent more than $40M on legal bills this year as his charges mount: Sources

FDA approves world's first CRISPR

American TikTok star stuck in Dubai for months following rental car altercation

Despite FDA approval for Lyfgenia, Bluebird faces stiff competition

Radiology is caught between AI's potential and concern for patients

Pfizer plans to depart BIO

Wikipedia

hotspot

hotspot

entertainment